Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel for Elderly Chinese Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Retrospective Cohort Study
ConclusionsTicagrelor was associated with a lower incidence of major adverse cardiovascular events than clopidogrel at 12 months in elderly Chinese patients with coronary artery disease, without a significant increase of Bleeding Academic Research Consortium bleeding events.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Academia | Angioplasty | Aspirin | Bleeding | Cardiology | Cardiovascular | China Health | Cholesterol | Clopidogrel | Coronary Angioplasty | Geriatrics | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Smokers | Study